Physician profile
Ammala Cantrell
NPI 1639159684
$1,137.52
in general payments reported to CMS, 2019-2025
12 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.09 · 2020: $32.54 · 2021: $13.32 · 2023: $415 · 2024: $81.36 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,008.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,007.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Cognition USA, INC. | $511.10 | 2025 | Zunveyl |
| Otsuka America Pharmaceutical, INC. | $165.29 | 2023-2024 | Rexulti, Nuedexta |
| Astrazeneca Pharmaceuticals LP | $164.97 | 2023-2024 | Farxiga, Airsupra |
| Sumitomo Pharma America, INC. | $115.10 | 2023-2024 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $35.32 | 2019 | |
| Janssen Pharmaceuticals, INC | $33.28 | 2019 | |
| Vivus LLC | $32.54 | 2020 | |
| Viiv Healthcare Company | $23.77 | 2023 | Apretude |
| Janssen Biotech, INC. | $15.49 | 2019 | |
| Sanofi Pasteur INC. | $13.70 | 2024 | |
| Exact Sciences Corporation | $13.64 | 2023 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $13.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammala Cantrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.